Background: The Abelson oncogene was initially identified as the viral transforming component of Abelson murine leukemia virus (A-MuLV). The Abelson gene (ABL1) encodes a SH2-domain bearing tyrosine kinase which conducts mitogenic signaling pursuant to growth factor receptor ligation. The Abl interactor proteins, Abi-1, Abi-2 and Abi-3, are SH3-domain containing proteins that bind to the proline-rich motifs of Abl and activate the kinase function. The Abi family members are thought to negatively regulate cell growth and transformation, including cellular transformation through v-Abl as well as mediate cell motility by regulating actin polymerization in lamellipodia and filopodia. Abi-3, also designated NESH, is a 366 amino acid protein that interacts with TARSH, a cellular senescence-related gene that acts as a trigger of tumor development.

Description: Rabbit polyclonal to ABI3

Immunogen: KLH conjugated synthetic peptide derived from ABI3

Specificity:  ·Reacts with Human, Mouse, Pig, Dog and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 39 kDa;

·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;

·Immunocytochemistry/Immunofluorescence: 1/100;

·Immunoprecipitation: 1/50;

·ELISA: 1/500;

·Optimal working dilutions must be determined by the end user.